Sale

Neurological Disease Treatment Market

Global Neurological Disease Treatment Market Size, Forecast: By Drug Type: Antiepileptic, Antipsychotic, Antidepressant, Cholinesterase Inhibitors, NMDA Receptor Antagonists, Others; By Disease Type: Alzheimer’s Disease, Others; By Route of Administration; By End Use; Regional Analysis; Competitive Landscape; 2024-2032

Global Neurological Disease Treatment Market Outlook

The global market for neurological disease treatment is expected to grow at a CAGR of about 5.7% in the forecast period of 2024-2032, owing to the increasing prevalence of neurological disorders.

 

neurological-disease-treatment-market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America to be a Significant Regional Market for Neurological Disease Treatment

The global market for neurological disease treatment is expected to be dominated by North America. One of the key reasons for the growth of the North American market is the increasing prevalence of neurological diseases across the region. According to the Alzheimer's Association, around 6 million people in the United States are currently living with Alzheimer's. The number of people suffering from this condition is projected to reach 13 million by 2050. An estimated 6.5 million Americans aged 65 and above will be living with Alzheimer's in 2023. Also, growing healthcare spending and the availability of a matured and well-established nature of healthcare infrastructure are expected to propel the market growth in North America. Government agencies, including the United States Food and Drug Administration, which manages central nervous system treatment regulatory guidelines, are expected to support the market's growth. Further, the launch of new treatments for treating these diseases, such as Huntington's disease, may drive the growth of the global neurological disease treatment market in the region. For instance, in December 2021, Novartis received approval from the US Food and Drug Administration (FDA) for Fast Track designation for branaplam (LMI070) for the treatment of Huntington's disease (HD).

 

Market Segmentations

Medically, neurological diseases are issues that affect the brain and the nerves found throughout the human body, including the spinal cord. Medicines may be administered via drug pumps, deep brain stimulation, spinal cord stimulation, rehabilitation/physical therapy after brain injury or stroke, and spinal surgery may be used to treat nervous system diseases or disorders.

 

neurological-disease-treatment-market-by-segmentation

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on drug type, the neurological disease treatment market is divided into:

  • Antiepileptic
  • Antipsychotic
  • Antidepressant
  • Cholinesterase Inhibitors
  • NMDA Receptor Antagonists
  • Others

The various types of disease studied in the market are:

  • Alzheimer’s Disease
  • Cerebrovascular Disease
  • Parkinson’s Disease
  • Epilepsy
  • Multiple Sclerosis
  • Others

By route of administration, the market can be divided into:

  • Oral
  • Parenteral
  • Others

The end-uses of the neurological disease treatment market are:

  • Hospitals
  • Speciality Clinics
  • Homecare
  • Others

The regional markets for neurological disease treatment can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

 

neurological-disease-treatment-market-by-region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Incidence of Neurological Diseases Propelling the Market Growth

The rapidly increasing prevalence and incidence of neurological disorders, such as multiple sclerosis, Parkinson's disease, and Alzheimer's disease, among others, are fuelling the expansion of the neurological disease treatment market. According to the National Library of Medicine, the predicted global population of people with multiple sclerosis reached 2.8 million in 2020. This rise is expected to have a significant impact on market growth in the coming years. The rising prevalence of neurological disorders and rising diagnosis rates in both developed and developing countries have resulted in a large patient pool requiring treatment. This is further assisted by non-profit organisations, healthcare institutions, and market participants focusing on raising awareness of these disorders through campaigns. These factors, together with the development of a new generation of antipsychotic medications by global and domestic market participants, are expected to fuel the market's growth potential. In addition, the rising research and development activities to find remedies for such ailments are driving the global market growth.

 

Key Players in the Global Market for Neurological Disease Treatment

The report gives a detailed analysis of the following key players in the global neurological disease treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • AbbVie Inc.
  • Abbott Laboratories
  • Merck & Co., Inc.
  • F. Hoffmann-La Roche Ltd
  • Gilead Sciences, Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Drug Type
  • Disease Type
  • Route of Administration
  • End Use
  • Region
Breakup by Drug Type
  • Antiepileptic
  • Antipsychotic
  • Antidepressant
  • Cholinesterase Inhibitors
  • NMDA Receptor Antagonists
  • Others
Breakup by Disease Type
  • Alzheimer’s Disease
  • Cerebrovascular Disease
  • Parkinson’s Disease
  • Epilepsy
  • Multiple Sclerosis
  • Others
Breakup by Route of Administration
  • Oral
  • Parenteral
  • Others
Breakup by End Use
  • Hospitals
  • Speciality Clinics
  • Homecare
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • AbbVie Inc.
  • Abbott Laboratories
  • Merck & Co., Inc.
  • F. Hoffmann-La Roche Ltd
  • Gilead Sciences, Inc.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Neurological Disease Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Neurological Disease Treatment Historical Market (2017-2023) 
    8.3    Global Neurological Disease Treatment Market Forecast (2024-2032)
    8.4    Global Neurological Disease Treatment Market by Drug Type
        8.4.1    Antiepileptic
            8.4.1.1    Historical Trend (2017-2023)
            8.4.1.2    Forecast Trend (2024-2032)
        8.4.2    Antipsychotic
            8.4.2.1    Historical Trend (2017-2023)
            8.4.2.2    Forecast Trend (2024-2032)
        8.4.3    Antidepressant
            8.4.3.1    Historical Trend (2017-2023)
            8.4.3.2    Forecast Trend (2024-2032)
        8.4.4    Cholinesterase Inhibitors
            8.4.4.1    Historical Trend (2017-2023)
            8.4.4.2    Forecast Trend (2024-2032)
        8.4.5    NMDA Receptor Antagonists
            8.4.5.1    Historical Trend (2017-2023)
            8.4.5.2    Forecast Trend (2024-2032)
        8.4.6    Others
    8.5    Global Neurological Disease Treatment Market by Disease Type
        8.5.1    Alzheimer’s Disease
            8.5.1.1    Historical Trend (2017-2023)
            8.5.1.2    Forecast Trend (2024-2032)
        8.5.2    Cerebrovascular Disease
            8.5.2.1    Historical Trend (2017-2023)
            8.5.2.2    Forecast Trend (2024-2032)
        8.5.3    Parkinson’s Disease
            8.5.3.1    Historical Trend (2017-2023)
            8.5.3.2    Forecast Trend (2024-2032)
        8.5.4    Epilepsy
            8.5.4.1    Historical Trend (2017-2023)
            8.5.4.2    Forecast Trend (2024-2032)
        8.5.5    Multiple Sclerosis
            8.5.5.1    Historical Trend (2017-2023)
            8.5.5.2    Forecast Trend (2024-2032)
        8.5.6    Others
    8.6    Global Neurological Disease Treatment Market by Route of Administration
        8.6.1    Oral
            8.6.1.1    Historical Trend (2017-2023)
            8.6.1.2    Forecast Trend (2024-2032)
        8.6.2    Parenteral
            8.6.2.1    Historical Trend (2017-2023)
            8.6.2.2    Forecast Trend (2024-2032)
        8.6.3    Others
    8.7    Global Neurological Disease Treatment Market by End Use
        8.7.1    Hospitals
            8.7.1.1    Historical Trend (2017-2023)
            8.7.1.2    Forecast Trend (2024-2032)
        8.7.2    Speciality Clinics
            8.7.2.1    Historical Trend (2017-2023)
            8.7.2.2    Forecast Trend (2024-2032)
        8.7.3    Homecare
            8.7.3.1    Historical Trend (2017-2023)
            8.7.3.2    Forecast Trend (2024-2032)
        8.7.4    Others    
    8.8    Global Neurological Disease Treatment Market by Region
        8.8.1    North America
            8.8.1.1    Historical Trend (2017-2023) 
            8.8.1.2    Forecast Trend (2024-2032)
        8.8.2    Europe
            8.8.2.1    Historical Trend (2017-2023) 
            8.8.2.2    Forecast Trend (2024-2032)
        8.8.3    Asia Pacific
            8.8.3.1    Historical Trend (2017-2023) 
            8.8.3.2    Forecast Trend (2024-2032)
        8.8.4    Latin America
            8.8.4.1    Historical Trend (2017-2023) 
            8.8.4.2    Forecast Trend (2024-2032)
        8.8.5    Middle East and Africa
            8.8.5.1    Historical Trend (2017-2023) 
            8.8.5.2    Forecast Trend (2024-2032)
9    North America Neurological Disease Treatment Market Analysis
    9.1    United States of America 
        9.1.1    Historical Trend (2017-2023) 
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2017-2023) 
        9.2.2    Forecast Trend (2024-2032)
10    Europe Neurological Disease Treatment Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2017-2023) 
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2017-2023) 
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2017-2023) 
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2017-2023) 
        10.4.2    Forecast Trend (2024-2032)
    10.5    Others
11    Asia Pacific Neurological Disease Treatment Market Analysis
    11.1    China
        11.1.1    Historical Trend (2017-2023) 
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2017-2023) 
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2017-2023) 
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2017-2023) 
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Historical Trend (2017-2023) 
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Neurological Disease Treatment Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2017-2023) 
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2017-2023) 
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2017-2023) 
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa Neurological Disease Treatment Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2017-2023) 
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2017-2023) 
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2017-2023) 
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2017-2023) 
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    AbbVie Inc.
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    Abbott Laboratories
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    Merck & Co., Inc.
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    F. Hoffmann-La Roche Ltd
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    Gilead Sciences, Inc.
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    Others
16    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Global Neurological Disease Treatment Market: Key Industry Highlights, 2017 and 2032
2.    Global Neurological Disease Treatment Historical Market: Breakup by Treatment Type (USD Million), 2017-2023
3.    Global Neurological Disease Treatment Market Forecast: Breakup by Treatment Type (USD Million), 2024-2032
4.    Global Neurological Disease Treatment Historical Market: Breakup by Disease Type (USD Million), 2017-2023
5.    Global Neurological Disease Treatment Market Forecast: Breakup by Disease Type (USD Million), 2024-2032
6.    Global Neurological Disease Treatment Historical Market: Breakup by End Use (USD Million), 2017-2023
7.    Global Neurological Disease Treatment Market Forecast: Breakup by End Use (USD Million), 2024-2032
8.    Global Neurological Disease Treatment Historical Market: Breakup by Region (USD Million), 2017-2023
9.    Global Neurological Disease Treatment Market Forecast: Breakup by Region (USD Million), 2024-2032
10.    North America Neurological Disease Treatment Historical Market: Breakup by Country (USD Million), 2017-2023
11.    North America Neurological Disease Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
12.    Europe Neurological Disease Treatment Historical Market: Breakup by Country (USD Million), 2017-2023
13.    Europe Neurological Disease Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
14.    Asia Pacific Neurological Disease Treatment Historical Market: Breakup by Country (USD Million), 2017-2023
15.    Asia Pacific Neurological Disease Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
16.    Latin America Neurological Disease Treatment Historical Market: Breakup by Country (USD Million), 2017-2023
17.    Latin America Neurological Disease Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
18.    Middle East and Africa Neurological Disease Treatment Historical Market: Breakup by Country (USD Million), 2017-2023
19.    Middle East and Africa Neurological Disease Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
20.    Global Neurological Disease Treatment Market Structure.

Key Questions Answered in the Report

The market is projected to grow at a CAGR of 5.7% between 2024 and 2032.

The major drivers of the market include the growing healthcare spending, availability of a matured and well-established nature of healthcare infrastructure, launch of new treatments for treating these diseases, rising awareness of these disorders, and rising research and development activities.

The rapidly increasing prevalence and incidences of neurological disorders, such as multiple sclerosis, Parkinson's disease, and Alzheimer's disease, and the rising diagnosis rates in both developed and developing countries are the key industry trends propelling the growth of the market.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Based on drug type, the market is divided into antiepileptic, antipsychotic, antidepressant, cholinesterase inhibitors, and NMDA receptor antagonists, among others.

The various types of disease studied in the market are Alzheimer’s disease, Cerebrovascular disease, Parkinson’s disease, epilepsy, and multiple sclerosis, among others.

Based on route of administration, the market includes oral and parenteral, among others.

The end-uses of the market are hospitals, speciality clinics, and homecare, among others.

The major players in the industry are AbbVie Inc., Abbott Laboratories, Merck & Co., Inc., F. Hoffmann-La Roche Ltd, and Gilead Sciences, Inc., among others.

Analyst Review

The global neurological disease treatment market was driven by the rapidly increasing prevalence and incidence of neurological disorders, such as multiple sclerosis, Parkinson's disease, and Alzheimer's disease in the historical period. Aided by the growing healthcare spending and rising diagnosis rates in both developed and developing countries, the market is expected to grow at a CAGR of 5.7% in the forecast period of 2024-2032.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on drug type, the market is divided into antiepileptic, antipsychotic, antidepressant, cholinesterase inhibitors, and NMDA receptor antagonists, among others. The various types of disease studied in the market are Alzheimer’s disease, Cerebrovascular disease, Parkinson’s disease, epilepsy, and multiple sclerosis, among others. Based on route of administration, the market includes oral and parenteral, among others. The end-uses of the market are hospitals, speciality clinics, and homecare, among others. The major regional markets for neurological disease treatment are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. The key players in the above market are AbbVie Inc., Abbott Laboratories, Merck & Co., Inc., F. Hoffmann-La Roche Ltd, and Gilead Sciences, Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER